3-Year Results of a TAVR Trial in High Surgical Risk Patients

Journal of the American College of Cardiology

Volumn 67, Issue 22, 2016, Pages 2575-2577

  Kumbhani, Dharam J ^a   Banerjee, Subhash ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

clinical trial; editorial; long term results; self expanding; TAVR

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; EDITORIAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE REPLACEMENT; RISK; RISK FACTOR;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RISK; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84977641513     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.526     Document Type: Editorial

References (18)

1. 1 Cribier, A., Eltchaninoff, H., Bash, A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002), 3006–3008.
2. 2 Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Engl J Med 363 (2010), 1597–1607.
3. 3 Popma, J.J., Adams, D.H., Reardon, M.J., et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63 (2014), 1972–1981.
4. 4 Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), e57–e185.
5. 5 Smith, C.R., Leon, M.B., Mack, M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Engl J Med 364 (2011), 2187–2198.
6. 6 Mack, M.J., Leon, M.B., Smith, C.R., et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.
7. 7 Deeb, G.M., Reardon, M.J., Chetcuti, S., et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67 (2016), 2565–2574.
8. 8 Adams, D.H., Popma, J.J., Reardon, M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. New Engl J Med 370 (2014), 1790–1798.
9. 9 Reardon, M.J., Adams, D.H., Kleiman, N.S., et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66 (2015), 113–121.
10. 10 Waksman, R., Pichard, A.D., Will TAVR become the default treatment for patients with severe aortic stenosis?. J Am Coll Cardiol 66 (2015), 122–124.
11. 11 Kapadia, S.R., Leon, M.B., Makkar, R.R., et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2485–2491.
12. 12 Gutmann, A., Kaier, K., Sorg, S., et al. Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System. Int J Cardiol 179 (2015), 231–237.
13. 13 Sweeney, M.O., Hellkamp, A.S., Heart failure during cardiac pacing. Circulation 113 (2006), 2082–2088.
14. 14 Emery, R.W., Krogh, C.C., Arom, K.V., et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 79 (2005), 776–782 discussion 782–3.
15. 15 Makkar, R.R., Fontana, G., Jilaihawi, H., et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. New Engl J Med 373 (2015), 2015–2024.
16. 16 Pibarot, P., Hahn, R.T., Weissman, N.J., Monaghan, M.J., Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. J Am Coll Cardiol Img 8 (2015), 340–360.
17. 17 Holmes, D.R. Jr., Mack, M.J., Kaul, S., et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59 (2012), 1200–1254.
18. 18 Reinohl, J., Kaier, K., Reinecke, H., et al. Effect of availability of transcatheter aortic-valve replacement on clinical practice. New Engl J Med 373 (2015), 2438–2447.